Estados Unidos · Plataformas y datos · Yahoo Finance

Daré Bioscience Surpasses $43 Million in Non-Dilutive Grant Funding as Investigational Programmable Drug Delivery Platform Gains Momentum

Publicado por Yahoo Finance · Estados Unidos hace 8 h

Latest $1.5 Million Installment Reflects Continued Milestone Progress as DARE-LARC1 Advances in Preclinical Development Company Exploring Potential Strategic Collaborations for…

Leer el artículo completo en Yahoo Finance Inicie sesión para guardar

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (finance.yahoo.com)

Daré Bioscience Surpasses $43 Million in Non-Dilutive Grant Funding as Investigational Programmable Drug Delivery Platform Gains Momentum

También te puede interesar

Gilead Sciences, Inc. (NASDAQ:GILD) Shareholders to Collect $0.82 Quarterly Dividend

AutoNation revenue beats estimates despite decline in vehicle sales

Think You Missed Out on Micron's Run? Think Again.

This one chart tells you everything you need to know about Exxon, Chevron and BP’s forecast-beating earnings

Hilton Grand Vacations announces $200 million accelerated share repurchase

Best Tech Stocks Right Now

Daré Bioscience Surpasses $43 Million in Non-Dilutive Grant Funding as Investigational Programmable Drug Delivery Platform Gains Momentum

Compartir

También te puede interesar

Gilead Sciences, Inc. (NASDAQ:GILD) Shareholders to Collect $0.82 Quarterly Dividend

AutoNation revenue beats estimates despite decline in vehicle sales

Think You Missed Out on Micron's Run? Think Again.

This one chart tells you everything you need to know about Exxon, Chevron and BP’s forecast-beating earnings

Hilton Grand Vacations announces $200 million accelerated share repurchase

Best Tech Stocks Right Now